Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Clinical practice. Treating smokers in the health care setting.

Fiore MC, Baker TB.

N Engl J Med. 2011 Sep 29;365(13):1222-31. doi: 10.1056/NEJMcp1101512. Review. No abstract available.

2.

Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.

Bailey SR, Crew EE, Riske EC, Ammerman S, Robinson TN, Killen JD.

Paediatr Drugs. 2012 Apr 1;14(2):91-108. doi: 10.2165/11594370-000000000-00000. Review.

3.

Smoking cessation: how to advise the patient.

Tonstad S.

Heart. 2009 Oct;95(19):1635-40. doi: 10.1136/hrt.2008.154476. No abstract available.

PMID:
19752210
4.
5.

The place of varenicline in smoking cessation treatment.

Aveyard P.

Thorax. 2008 Aug;63(8):666-8. doi: 10.1136/thx.2008.096081. No abstract available.

PMID:
18663065
6.

'Real-world' effectiveness of smoking cessation treatments: a population study.

Kotz D, Brown J, West R.

Addiction. 2014 Mar;109(3):491-9. doi: 10.1111/add.12429.

PMID:
24372901
7.

Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.

King DP, Paciga S, Pickering E, Benowitz NL, Bierut LJ, Conti DV, Kaprio J, Lerman C, Park PW.

Neuropsychopharmacology. 2012 Feb;37(3):641-50. doi: 10.1038/npp.2011.232.

8.

[Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].

Sicras Mainar A, Navarro Artieda R, Díaz Cerezo S, Martí Sánchez B, Sanz De Burgoa V.

Aten Primaria. 2011 Sep;43(9):482-9. doi: 10.1016/j.aprim.2010.09.010. Spanish.

9.

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR; Varenicline Phase 3 Study Group..

JAMA. 2006 Jul 5;296(1):56-63. Erratum in: JAMA. 2006 Sep 20;296(11):1355.

PMID:
16820547
10.

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group..

JAMA. 2006 Jul 5;296(1):47-55.

PMID:
16820546
11.

Prescribing of smoking cessation medication in England since the introduction of varenicline.

Langley TE, Huang Y, McNeill A, Coleman T, Szatkowski L, Lewis S.

Addiction. 2011 Jul;106(7):1319-24. doi: 10.1111/j.1360-0443.2011.03426.x.

PMID:
21395894
12.

Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.

Gonzales D, Jorenby DE, Brandon TH, Arteaga C, Lee TC.

Addiction. 2010 Nov;105(11):2002-13. doi: 10.1111/j.1360-0443.2010.03058.x.

13.

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.

West R, Baker CL, Cappelleri JC, Bushmakin AG.

Psychopharmacology (Berl). 2008 Apr;197(3):371-7.

PMID:
18084743
14.

Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey.

Kasza KA, Hyland AJ, Borland R, McNeill AD, Bansal-Travers M, Fix BV, Hammond D, Fong GT, Cummings KM.

Addiction. 2013 Jan;108(1):193-202. doi: 10.1111/j.1360-0443.2012.04009.x.

15.

Treating tobacco dependence in a medical setting.

Hurt RD, Ebbert JO, Hays JT, McFadden DD.

CA Cancer J Clin. 2009 Sep-Oct;59(5):314-26. doi: 10.3322/caac.20031.

16.

Integrating smoking cessation into HIV care.

Drach L, Holbert T, Maher J, Fox V, Schubert S, Saddler LC.

AIDS Patient Care STDS. 2010 Mar;24(3):139-40. doi: 10.1089/apc.2009.0274. No abstract available.

PMID:
20214480
17.

Non-nicotinic therapies for smoking cessation.

Siu EC, Tyndale RF.

Annu Rev Pharmacol Toxicol. 2007;47:541-64. Review.

PMID:
17209799
18.

Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice.

Brose LS, West R, Stapleton JA.

Mayo Clin Proc. 2013 Mar;88(3):226-33. doi: 10.1016/j.mayocp.2012.11.013.

PMID:
23489449
19.

Optimizing on smoke free legislation making the most of the opportunity.

Croghan E.

Br J Community Nurs. 2007 Aug;12(8):334-6. Review.

PMID:
17851296
20.

Smoking cessation in pregnancy: why, how, and what next...

Crawford JT, Tolosa JE, Goldenberg RL.

Clin Obstet Gynecol. 2008 Jun;51(2):419-35. doi: 10.1097/GRF.0b013e31816fe9e9. Review.

PMID:
18463471

Supplemental Content

Support Center